Mar 23, 2021 / NTS GMT
Presentation
Mar 23, 2021 / NTS GMT
=====================
Corporate Participants
=====================
* Adele M. Gulfo
Myovant Sciences Ltd. - Interim Chief Commercial Officer & Director
* Bill McMahon
* Dan Rothman
* Hiroshi Nomura
Sumitomo Dainippon Pharma Co., Ltd. - CEO, President & Representative Director
* Hiroyuki Baba
Sumitomo Dainippon Pharma Co., Ltd. - Senior Executive Officer of Global Data Design Office
* Myrtle Potter
* Sam Azoulay
* Toru Kimura
Sumitomo Dainippon Pharma Co., Ltd. - Senior Executive Officer, Chief Scientific Officer & Director
=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Motoya Kohtani
Nomura Securities Co. Ltd., Research Division -
Sumitomo Pharma Co Ltd
(OTCPK:DNPUF)
$
8.4
(0%)
Market Cap: 3.52 Bil
Enterprise Value: 4.54 Bil
PE Ratio: 4.78
PB Ratio: 1.74
GF Score: 65/100 Sumitomo Dainippon Pharma Co Ltd Sumitovant Presentation Transcript
Mar 23, 2021 / NTS GMT
Release Date Price:
$18.75
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot